KCAS has extensive experience in validating methods in a wide range of bioanalytical platforms. Our methods are designed to meet regulatory compliance with FDA, EMA, Health Canada and can meet guidelines for other international agencies.
Our scientists have validated over 5,000 bioanalytical methods over the last 40 years, covering every drug class. We specialize in tackling difficult compounds, meeting requirements for micro sampling and capable of analyzing a wide range of biological fluids and tissues.
Our extensive experience in supporting drug development over the years makes KCAS uniquely qualified in finding a solution for our clients.
COMPOUND CLASSES
- Small Molecules
- Metabolites
- Endogenous Molecules
- ADCs (Free and Total)
- Metals
- ADCs (Mab, ADA)
- Amino Acids
- Biomarkers
- Cell Surface Receptors
- Fusion Proteins
- Glycosphingolipids
- Large Molecules (NBEs)
- Lipids
- Monoclonal Antibodies (mAbs)
- Multi-Valent Antibodies
- Oligonucleotides
- Novel Frameworks
- PEGylated Proteins
- Peptides
- Proteins
- RNA / DNA
- Signaling Pathways